regulatory approval

News

Datroway is first TROP2 drug for frontline breast cancer

AZ and Daiichi's Datroway has been cleared by the FDA as first-line treatment for triple-negative breast cancer patients ineligible for immunotherapy.

News

Gilead claims first FDA nod for a hepatitis D therapy

At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.

News

AZ gets first okay for new hypertension drug baxdrostat

AstraZeneca is the first company to get FDA approval for an aldosterone synthase inhibitor for hypertension, ahead of rival Mineralys.

News

FDA hands BeOne, Taiho approvals for blood cancers

BeOne gets the nod for BCL2 inhibitor Beqalzi in mantle cell lymphoma, while Taiho's Inqovi has acute myeloid leukaemia added to its label.

News

Partner's Bizengri is first drug for rare, aggressive cancer

Partner's Bizengri has been approved for a rare form of bile duct cancer, two days after being awarded a national priority review voucher.

News

Pfizer, Arvinas join SERD club with Veppanu approval

Arvinas and Pfizer's Veppanu is the first PROTAC – and third oral SERD for breast cancer – to be approved by the FDA.

Datroway is first TROP2 drug for frontline breast cancer

Gilead claims first FDA nod for a hepatitis D therapy

AZ gets first okay for new hypertension drug baxdrostat

FDA hands BeOne, Taiho approvals for blood cancers

Partner's Bizengri is first drug for rare, aggressive cancer

Pfizer, Arvinas join SERD club with Veppanu approval

NHS use of Incyte's anal cancer drug Zynyz backed by NICE

Securing your ROI: Turning post-acquisition integration into...

regulatory approval

Editor's Picks